This information was published on 2026-01-21T07:17:39 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2613421 (IR 1892909) |
| (220) |
11 Nov 2025
|
| (300) |
GB, 02 Jul 2025, UK00004228173
|
| (511) (510) |
Class 5
Fertility-enhancing drugs; pharmaceuticals and medical preparations; pharmaceutical and medical preparations for fertility treatments; ovulation stimulants; drugs that stimulate ovulation to aid in conception; supplements for reproductive health; diagnostic reagents for medical use; implantation support supplements; hormonal therapies being pharmaceutical preparations; In vitro fertilization (IVF) media; cryopreservation solutions; semen analysis kits; endometrial receptivity tests; luteal phase support; tests to measure ovarian reserve and predict response to fertility treatments; tests to evaluate ovarian function and fertility potential; nutrient solutions used to support the growth of embryos in the lab; implantation support supplements. |
| (540) | LYVANTA |
| (550) | Word |
| (730) |
U-Ploid Biotechnologies Ltd
|
Find out more about publications on the About page.